Package 72606-051-02
Brand: tocilizumab-anoh
Generic: tocilizumabPackage Facts
Identity
Package NDC
72606-051-02
Digits Only
7260605102
Product NDC
72606-051
Description
4 SYRINGE, GLASS in 1 CARTON (72606-051-02) / .9 mL in 1 SYRINGE, GLASS
Marketing
Marketing Status
Brand
tocilizumab-anoh
Generic
tocilizumab
Sample Package
No
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "bacf86b8-9d2f-45d2-9c35-4f619ea494aa", "openfda": {"nui": ["N0000190478", "N0000190480"], "unii": ["I031V2H011"], "rxcui": ["2705425", "2705435", "2705443", "2705450", "2705452"], "spl_set_id": ["60381a7e-d7ae-4384-925d-c19c418d1663"], "pharm_class_epc": ["Interleukin-6 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Interleukin 6 Receptor Antagonists [MoA]"], "manufacturer_name": ["CELLTRION USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE, GLASS in 1 CARTON (72606-051-01) / .9 mL in 1 SYRINGE, GLASS", "package_ndc": "72606-051-01", "marketing_start_date": "20250126"}, {"sample": false, "description": "4 SYRINGE, GLASS in 1 CARTON (72606-051-02) / .9 mL in 1 SYRINGE, GLASS", "package_ndc": "72606-051-02", "marketing_start_date": "20250126"}, {"sample": false, "description": "12 SYRINGE, GLASS in 1 CARTON (72606-051-03) / .9 mL in 1 SYRINGE, GLASS", "package_ndc": "72606-051-03", "marketing_start_date": "20250126"}, {"sample": false, "description": "1 SYRINGE, GLASS in 1 CARTON (72606-051-04) / .9 mL in 1 SYRINGE, GLASS", "package_ndc": "72606-051-04", "marketing_start_date": "20250126"}, {"sample": false, "description": "4 SYRINGE, GLASS in 1 CARTON (72606-051-05) / .9 mL in 1 SYRINGE, GLASS", "package_ndc": "72606-051-05", "marketing_start_date": "20250126"}, {"sample": false, "description": "12 SYRINGE, GLASS in 1 CARTON (72606-051-06) / .9 mL in 1 SYRINGE, GLASS", "package_ndc": "72606-051-06", "marketing_start_date": "20250126"}], "brand_name": "Tocilizumab-anoh", "product_id": "72606-051_bacf86b8-9d2f-45d2-9c35-4f619ea494aa", "dosage_form": "INJECTION, SOLUTION, CONCENTRATE", "pharm_class": ["Interleukin 6 Receptor Antagonists [MoA]", "Interleukin-6 Receptor Antagonist [EPC]"], "product_ndc": "72606-051", "generic_name": "tocilizumab", "labeler_name": "CELLTRION USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tocilizumab-anoh", "active_ingredients": [{"name": "TOCILIZUMAB", "strength": "162 mg/.9mL"}], "application_number": "BLA761420", "marketing_category": "BLA", "marketing_start_date": "20250126", "listing_expiration_date": "20271231"}